Select your Language: हिन्दी

Covid-19 Vaccine India: Ahmedabad Firm Gets Nod For Human Trial.

Shubham Jaiswal (

After Covaxin, another potential COVID-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the Drugs Controller General of India (DCGI) on Thursday for human clinical trials, government sources said.

The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency and unmet medical need during the pandemic.

Dr V G Somani (DCGI) has given approval for the phase 1st and 2nd clinical trials (on humans) of the potential novel COVID-19 vaccine developed by Zydus Cadila Healthcare Ltd on Thursday after its Animal Studies were found to be successful.


Related Articles

Back to top button